BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.04 and traded as low as $0.01. BIOLASE shares last traded at $0.01, with a volume of 134,152 shares.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. StockNews.com began coverage on BIOLASE in a research report on Tuesday. They issued a “sell” rating for the company. Benchmark reissued a “speculative buy” rating and issued a $0.40 price objective on shares of BIOLASE in a report on Wednesday, October 2nd.
Get Our Latest Stock Report on BIOLASE
BIOLASE Price Performance
BIOLASE Company Profile
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.
Read More
- Five stocks we like better than BIOLASE
- Upcoming IPO Stock Lockup Period, Explained
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Bank Stocks – Best Bank Stocks to Invest In
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.
